Results 71 to 80 of about 3,368,671 (295)
Raymond Alexanian, MD, Oral History Interview, May 15, 2014 [PDF]
, 2014 Major Topics Covered: Personal and educational background; Evolution of research on erythropoietin; Evolution of research and contributions to treatment of myeloma; History of medical education; History of myeloma treatment; Committees at MD Anderson ...
Rosolowski, Tacey A., PhD +1 more
core
Prospecting the protein design landscape
FEBS Letters, EarlyView.This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona +4 more
wiley +1 more source
Artificial molecular machines and motors—Design and control of nanoscale motion
FEBS Letters, EarlyView.Molecules are constantly moving because of thermal fluctuations, but random motion alone cannot be exploited to perform directional tasks. Artificial molecular machines use chemical, electrical, or light energy to bias this motion. Molecular shuttles, rotary motors, and supramolecular pumps illustrate how nanoscale movement can be controlled and ...
Leonardo Andreoni, Alberto Credi
wiley +1 more source
, 2016 A photo of our namesake and the man whose gift made MD Anderson possible is held in front of our Donor Wallhttps://openworks.mdanderson.org/mdacc75thenow_img/1002/thumbnail ...
The University of Texas MD Anderson Cancer Center
core
Alma Rodriguez, MD, Oral History Interview, June 05, 2015 [PDF]
, 2015 Major Topics Discussed: Quality indicators and patient centered care The Survivorship Program MD Anderson growth and changes in culture; evaluation of Ronald DePinho’s agenda Economics of healthcare and impact on MD Andersonhttps://openworks ...
Rodriguez, Alma, MD +1 more
core
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
FEBS Letters, EarlyView.Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos +9 more
wiley +1 more source
Thomas A. Buchholz, MD, Oral History Interview, March 8, 2018 [PDF]
, 2018 Major Topics Covered: Leadership: examples of effective decision-making, critique of “stumbles” MD Anderson in transition under Ronald DePinho and after his resignation UT System’s relationship to MD Anderson leadership Epic: transition to, value of ...
Rosolowski, Tacey A., PhD +1 more
core
FEBS Letters, EarlyView.Transient oligomers formed by intrinsically disordered proteins may be ‘invisible’ to direct detection yet remain accessible to solution NMR through equilibrium‐exchange measurements and pressure‐jump experiments. Complementary methods report on mass, stoichiometry, selected distance distributions, morphology, and internal packing.
Martin D. Gelenter, Ad Bax
wiley +1 more source
John Mendelsohn, MD, Oral History Interview, September 28, 2012 [PDF]
Major Topics Covered: MD Anderson mission and culture Indigent care Overseeing MD Anderson growth: mission areas, translational research, physical plant Dr. Mendelsohn’s “cancer care cycle” and the MD Anderson Instituteshttps://openworks.mdanderson.org/
Mendelsohn, John, MD +1 more
core
Norman Leeds, MD, Oral History Interview, May 30, 2017 [PDF]
, 2017 Major Topics Covered: Personal background and education; two-career marriage Professional trajectory prior to MD Anderson Participation in and perspectives on the formative years of neuroradiology Research contributions to neuro-radiology Change at MD ...
Leeds, Norman, MD +1 more
core